Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Phase 3 TRIUMPH trials have shown average weight loss of up to 28.7%, the highest ever recorded in an obesity drug trial
What was studied: The incidence of major adverse cardiovascular events Outcome: Semaglutide reduced the relative risk of adverse cardiovascular events by 20%, translating to an absolute reduction of 1.5 percentage points, from 8.0% in placebo participants to 6.5% in semaglutide participants
The International Consortium of Investigative Journalists reports that federal authorities in Mexico seized vials labeled as the cancer drug Keytruda during an operation to dismantle a counterfeit medicine ring
Our journey at TrimRx began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions, and understanding these mechanisms is a core part of that commitment
00188-2/asset/9ea5f54d-addc-413f-a5f5-068aaced3d20/main.assets/gr1.jpg)
